A new offer by Valeant to buy Allergan

Valeant has upped its unsolicited takeover bid for Allergan and invited its directors to a meeting.

 

The new offer is US $58.30 per share, an increase of US $10 over the previous offer. As with its last attempt, Valeant is also offering 0.83 Valeant share for each Allergan share, bringing the overall offer to approximately US $50 billion. As well, Valeant is promising to pay up to US $25 per share based on the success of Darpin, an ophthalmological drug being developed by Allergan. Valeant would invest up to US $400 million in this drug and would retain the employees responsible for its development. 

 

Valeant CEO Michael Pearson has also invited Allergan’s directors to meet with them, stating that Allergan’s recent public attack on Valeant’s business model reveals a lack of understanding of the pharmaceutical company’s operations and performance. Pearson continues to maintain that Valeant’s strategy would create substantial short, medium and long-term returns for Allergan shareholders.

 

“Just as importantly, we believe that together the two companies will be better able to serve the patient and the medical communities with a more complete product offer and ongoing innovations,” he added.

 

Allergan’s board will examine the offer before making recommendations to its shareholders.

Sources:

http://ir.valeant.com/investor-relations/news-releases/news-release-details/2014/Valeant-Substantially-Increases-Merger-Proposal-For-Allergan/default.aspx

http://www.ledevoir.com/economie/actualites-economiques/409481/valeant-offre-plus-d-argent-comptant-pour-allergan

 

 

 

Featured Posts

Flirty Cat-Eye Sunnies from OTPS are Totally Trending

OTPS-2031’s Rose Tortoise is a fun and flirty frame created using colourful patterned biodegradable acetate.

Learn More

25,700+ Accept WCO Myopia Management Standard of Care Pledge Challenge

Global Organizations and Eye Care Professionals Pledge to Embrace the Three Pillars of Myopia Management

Read more

February is AMD Awareness Month Recognizing the Leading Cause of Vision Loss in Seniors

Fighting Blindness Canada (FBC) is marking Age-Related Macular Degeneration (AMD) Awareness Month with activities to inform and educate Canadians about the leading cause of vision loss in people over the age of 55, impacting approximately 2.5 million Canadians.

Read more

MIDO 2023 is Ready: All Eyes on the International Eyewear Show

Appointment with MIDO at Fiera Milano Rho Saturday, February 4 to Monday, February 6

Read more

February is IRIS Mundial Month for Sixteenth Year

IRIS Mundial announces that, for a 16th year, the organization will benefit from an annual fundraising campaign organized by IRIS, The Visual Group, its main partner.

Read more

Flirty Cat-Eye Sunnies from OTPS are Totally Trending

OTPS-2031’s Rose Tortoise is a fun and flirty frame created using colourful patterned biodegradable acetate.

Learn More

25,700+ Accept WCO Myopia Management Standard of Care Pledge Challenge

Global Organizations and Eye Care Professionals Pledge to Embrace the Three Pillars of Myopia Management

Read More

February is AMD Awareness Month Recognizing the Leading Cause of Vision Loss in Seniors

Fighting Blindness Canada (FBC) is marking Age-Related Macular Degeneration (AMD) Awareness Month with activities to inform and educate Canadians about the leading cause of vision loss in people over the age of 55, impacting approximately 2.5 million Canadians.

Read More

MIDO 2023 is Ready: All Eyes on the International Eyewear Show

Appointment with MIDO at Fiera Milano Rho Saturday, February 4 to Monday, February 6

Read More

February is IRIS Mundial Month for Sixteenth Year

IRIS Mundial announces that, for a 16th year, the organization will benefit from an annual fundraising campaign organized by IRIS, The Visual Group, its main partner.

Read More

Flirty Cat-Eye Sunnies from OTPS are Totally Trending

OTPS-2031’s Rose Tortoise is a fun and flirty frame created using colourful patterned biodegradable acetate.

Learn More

25,700+ Accept WCO Myopia Management Standard of Care Pledge Challenge

Global Organizations and Eye Care Professionals Pledge to Embrace the Three Pillars of Myopia Management

Read more

February is AMD Awareness Month Recognizing the Leading Cause of Vision Loss in Seniors

Fighting Blindness Canada (FBC) is marking Age-Related Macular Degeneration (AMD) Awareness Month with activities to inform and educate Canadians about the leading cause of vision loss in people over the age of 55, impacting approximately 2.5 million Canadians.

Read more

MIDO 2023 is Ready: All Eyes on the International Eyewear Show

Appointment with MIDO at Fiera Milano Rho Saturday, February 4 to Monday, February 6

Read more

February is IRIS Mundial Month for Sixteenth Year

IRIS Mundial announces that, for a 16th year, the organization will benefit from an annual fundraising campaign organized by IRIS, The Visual Group, its main partner.

Read more

Flirty Cat-Eye Sunnies from OTPS are Totally Trending

OTPS-2031’s Rose Tortoise is a fun and flirty frame created using colourful patterned biodegradable acetate.

Learn More

25,700+ Accept WCO Myopia Management Standard of Care Pledge Challenge

Global Organizations and Eye Care Professionals Pledge to Embrace the Three Pillars of Myopia Management

Read more

February is AMD Awareness Month Recognizing the Leading Cause of Vision Loss in Seniors

Fighting Blindness Canada (FBC) is marking Age-Related Macular Degeneration (AMD) Awareness Month with activities to inform and educate Canadians about the leading cause of vision loss in people over the age of 55, impacting approximately 2.5 million Canadians.

Read more

MIDO 2023 is Ready: All Eyes on the International Eyewear Show

Appointment with MIDO at Fiera Milano Rho Saturday, February 4 to Monday, February 6

Read more

February is IRIS Mundial Month for Sixteenth Year

IRIS Mundial announces that, for a 16th year, the organization will benefit from an annual fundraising campaign organized by IRIS, The Visual Group, its main partner.

Read more